• Food and Drug Administration
    Comprehensive Ophthalmology

    Cantrell Drug Company has issued a voluntary nationwide recall of unexpired sterile drug products due to concerns over sterility assurance. Affected product lots include all those distributed between February 16 and July 19, 2017, packaged in syringes or IV bags. Products were sold to health care facilities in all states except Connecticut, Hawaii, South Carolina and Vermont. 

    Click here for a full list of Cantrell products

    According to a press release, Cantrell is currently notifying customers by email and phone and arranging for the return of all recalled products. Anyone with a product subject to the recall should stop using it and contact the company.

    To date, there have been no reports of adverse events attributed to the affected drugs lots.

    Physicians and patients may report adverse reactions or quality problems to the FDA’s MedWatch Adverse Event Reporting.  

    To report by mail or fax: Download the reporting form or call 1-800-332-1088 to request one, and then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178